Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
Citation
Wilkinson, B, Day, S, Malins, L et al 2011, 'Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer', Angewandte Chemie International Edition, vol. 50, pp. 1635-1639.Year
2011ANU Authors
Field of Research
- Organic Chemical Synthesis